The increase of estrogen levels in breast tumors as compared to surrounding tissues has been suggested to be a consequence of enhanced uptake of estrogens from the circulation and binding of estrogens to ER, rather than in situ estrogen synthesis in the tumor [21, 29]. The gene discussed is ESR1; the disease is neoplasm.